Unesbulin in Women With Ovarian Cancer Receiving Neoadjuvant Chemotherapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This is an open-label Phase Ib dose-escalation study to determine the safety, tolerability, and pharmacokinetics of Unesbulin when combined with and following conventional chemotherapy and as maintenance therapy as a capsule (weight based dosing) and a tablet (fixed dosing) in women with epithelial ovarian, fallopian tube or primary peritoneal cancer which is previously untreated.
Epistemonikos ID: f29fce6c625ae91e910891be2f9f2c61d1c68aff
First added on: May 20, 2024